Neuroscience
ePoster - FLOODLIGHT AAN 2018 - Remote Self-Monitoring is Accepted by Patients and Provides Meaningful, Continuous Sensor-Based Outcomes Consistent With and Augmenting Conventional In-Clinic Measures
Dec 01, 2021
by [X Montalban, P Mulero, L Midaglia, J Graves, SL Hauser, L Julian, M Baker, J Schadrack, C Gossens, A Scotland, F Lipsmeier, G Pointeau, C Bernasconi, S Belachew, M Lindemanna]
FLOODLIGHT is a prospective pilot study to assess the feasibility of remote patient monitoring using smartphones and smartwatches in patients with MS and healthy controls. This analysis reports interim results of adherence, results from a patient satisfaction questionnaire (PSQ) and correlations between smartphone-based and in-clinic tests from FLOODLIGHT.
Enter the password to open this PDF file:
File name:
-
File size:
-
Title:
-
Author:
-
Subject:
-
Keywords:
-
Creation Date:
-
Modification Date:
-
Creator:
-
PDF Producer:
-
PDF Version:
-
Page Count:
-
Preparing document for printing…
0%
Related Content
-
Also In AAN 2018:
AAN 2018 poster: Optimizing the gantenerumab phase 3 dosing regimen through PK-PD modeling and clinical trial simulations
-
Also In AAN 2018:
AAN 2018 oral presentation: Higher Dose Gantenerumab leads to Significant Reduction in Amyloid Plaque Burden: Results for the Marguerite and Scarlet Road Open Label Extension Studies
-
Also In AAN 2018:
AAN 2018 poster- Safety, tolerability and pharmacokinetics of crenezumab in mild-to-moderate AD patients treated with escalating doses for up to 32 months